2016: EMA received highest No. of initial applications for biosimilars

Asphalion has large experience in Biosimilars and is glad to highlight this positive trend in EU

Asphalion has large experience in Biosimilars and is glad to highlight this positive trend in EU
June 15, 2017

The initial
evaluation includes all activities relating to the processing of
marketing-authorization applications (MAA) for new medicines which have never
been assessed before. It covers from the pre-submission discussion with future
applicants, through evaluation by the CHMP, to the granting of a marketing
authorization by the European Commission.

An upward
trend is being observed over the last five years. In 2013, 80 applications for
medicinal products were received, while in 2016 it reached 114 applications.

Especial
increase has been detected in biosimilar products achieving in 2016 the highest
number of applications in a year so far with 14 new applications.

Asphalion
would like to highlight this record as we are currently working in many
biosimilar projects. We have large experience in biosimilar’s Scientific
Advice, dossier preparation, due diligence, RMP, publishing, assistance during
product development and many more services.

We also
have experience in FDA biosimilar projects such as BLA, IND meeting and
publishing.

If you have
a biosimilar project we can help you on regulatory requirements in EMA and FDA.
Contact us at
info@asphalion.com and get more information!

Search News & Events

  • Filter by category

Share

Related news and events

Christmas season greatings

Season’s Greetings

We wish you Happy ‘Xmas, Prosperous New Year and Health for you and your loved ones.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting